Table 4.
Baseline characteristics of participants associated with heart failure (HF)
| Variable | HF, N = 5001 | CON, N = 15,8051 | p-value2 |
|---|---|---|---|
| AGE, Median (IQR) | 70.00 (60.00–78.00) | 48.00 (34.00–63.00) | < 0.001 |
| PIR, Median (IQR) | 1.57 (1.02–2.89) | 2.17 (1.14–4.12) | < 0.001 |
| TC, Median (IQR) | 170.00 (142.00–202.00) | 190.00 (164.00–218.00) | < 0.001 |
| A1 C, Median (IQR) | 5.95 (5.50–6.63) | 5.50 (5.20–5.80) | < 0.001 |
| TG, Median (IQR) | 115.00 (81.75–166.25) | 103.00 (72.00–150.00) | < 0.001 |
| LDL-C, Median (IQR) | 93.50 (70.75–121.00) | 112.00 (90.00–136.00) | < 0.001 |
| INSULIN, Median (IQR) | 11.40 (6.40–22.71) | 9.36 (5.89–15.41) | < 0.001 |
| HDL-C, Median (IQR) | 1.22 (1.01–1.50) | 1.34 (1.11–1.63) | < 0.001 |
| PFG, Median (IQR) | 109.00 (98.00–130.00) | 100.00 (92.30–110.00) | < 0.001 |
| BMI, Median (IQR) | 30.10 (25.88–35.46) | 27.80 (24.20–32.24) | < 0.001 |
| WAIST, Median (IQR) | 107.40 (94.93–119.50) | 97.40 (87.50–108.20) | < 0.001 |
| VAI, Median (IQR) | 163.10 (91.54–267.16) | 125.62 (76.96–208.98) | < 0.001 |
| TyG, Median (IQR) | 8.79 (8.37–9.28) | 8.57 (8.17–9.00) | < 0.001 |
| TG/HDL-C, Median (IQR) | 94.81 (57.77–156.31) | 75.86 (46.38–124.59) | < 0.001 |
| METS-IR, Median (IQR) | 1.82 (1.70–1.93) | 1.71 (1.61–1.81) | < 0.001 |
| HOMA-IR, Median (IQR) | 3.11 (1.70–6.97) | 2.37 (1.42–4.15) | < 0.001 |
| Gender, n (%) | < 0.001 | ||
| Male | 278 (56) | 7,603 (48) | |
| Female | 222 (44) | 8,202 (52) | |
| Race, n (%) | < 0.001 | ||
| Mexican American | 42 (8.4) | 2,555 (16) | |
| Other Hispanic | 36 (7.2) | 1,370 (8.7) | |
| Non-Hispanic White | 288 (58) | 7,069 (45) | |
| Non-Hispanic Black | 108 (22) | 3,145 (20) | |
| Other Race—Including Multi-Racial | 26 (4.4) | 1,666 (11) |
1Median (IQR) or Frequency (%)
2Wilcoxon rank sum test; Pearson's Chi-squared test